The Health Ministry has said there are no plans to ban Ranitidine despite concerns over NDMA impurities linked to certain ...

In 2019, evidence showed that an impurity in drug degrades over time to form probable carcinogenic compound. Ranitidine is ...

At present, there is no proposal to prohibit the manufacture, distribution and sale of Ranitidine, a medication used to ...

as it implemented a ban on new and existing prescriptions for the gastrointestinal drug, commonly known as Zantac and used to treat conditions like heartburn. Low levels of NDMA are ingested in ...

Any company manufacturing Ranitidine will face the same issue; the reason why the United States Food and Drug Administration (USFDA) and the European Medical Agency (EMA) stopped the sale of the ...

Health authorities say there is no immediate risk, but patients have been advised to consult a doctor who can prescribe alternatives to ranitidine. On 13 September, both the US Food and Drug ...

The Indian government currently has no plans to ban Ranitidine, a stomach acid reducer, despite international concerns about impurities. Actions include testing and communication with drug ...

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies ...

also known by its generic name ranitidine, has received pushback from the Food and Drug Administration after it was found to contain potentially high levels of N-nitrosodimethylamine (NDMA), which ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs.